Cargando…
Drug Potency Prediction of SARS-CoV-2 Main Protease Inhibitors Based on a Graph Generative Model
The prediction of a ligand potency to inhibit SARS-CoV-2 main protease (M-pro) would be a highly helpful addition to a virtual screening process. The most potent compounds might then be the focus of further efforts to experimentally validate their potency and improve them. A computational method to...
Autores principales: | Fadlallah, Sarah, Julià, Carme, García-Vallvé, Santiago, Pujadas, Gerard, Serratosa, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218534/ https://www.ncbi.nlm.nih.gov/pubmed/37240128 http://dx.doi.org/10.3390/ijms24108779 |
Ejemplares similares
-
A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?
por: Macip, Guillem, et al.
Publicado: (2021) -
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
por: Gimeno, Aleix, et al.
Publicado: (2020) -
Haste makes waste: A critical review of docking‐based virtual screening in drug repurposing for SARS‐CoV‐2 main protease (M‐pro) inhibition
por: Macip, Guillem, et al.
Publicado: (2021) -
Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021) -
Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease
por: Behnam, Mira A. M., et al.
Publicado: (2021)